ACIBOFIL DM (Acebrophylline (200mg) + Desloratadine (5mg) + Montelukast (10mg))

Acibrofil DM is formulated with a combination of Acebrophylline SR at a dosage of 200 mg, Desloratadine at 5 mg, and Montelukast Sodium at 10 mg. This medication is primarily utilized to address respiratory ailments such as asthma and allergic rhinitis. Acebrophylline functions by mitigating inflammation within the lungs, thereby facilitating easier breathing. Desloratadine serves as an antihistamine, effectively alleviating symptoms associated with allergies. Additionally, Montelukast Sodium acts as a leukotriene receptor antagonist, which helps to obstruct asthma symptoms that may arise due to inflammatory processes. When these components work together, they offer significant relief from breathing challenges, allergic reactions, and complications linked to asthma. This multi-faceted approach allows for comprehensive management of symptoms, enhancing the overall quality of life for individuals suffering from these respiratory conditions. It is essential for patients to understand the importance of adhering to prescribed dosages and schedules to maximize the therapeutic benefits associated with Acibrofil DM while minimizing the potential risks of adverse reactions. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.